Nizam’s Institute of Medical Sciences (Nims) today took exception to the Central Bureau of Investigation (CBI) questioning the veracity of Satyam founder B Ramalingam Raju’s health report, saying he was not out of danger and could develop liver cirrhosis.
“The health condition of B Ramalinga Raju is precarious and there are chances of him developing liver cirrhosis,” said Ajit Kumar, professor and head of gastroenterology department at Nims. Raju was admitted to the hospital last September after he was diagnosed with Hepatitis C, a liver disorder. CBI had raised doubts about the report submitted by Nims’ doctors about Raju’s health condition.
Speaking to the media, Kumar said Raju had a chronic infection earlier, but now the virus had almost disappeared. “The virus count was 10 million and it has now come down to 30,” he said, adding that Raju had developed complications. “He is still not out of danger and there are chances of him getting infection again,” Kumar added.
He said the treatment followed for managing Hepatitis C was standard. “Once liver cirrhosis sets in, it cannot be treated in total and there might be a need for a liver transplant.”
Kumar said Nims was ready for a third-party verification. “The treatment is same for all. It does not matter if he is the king or a commoner.”
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
